Cancer research brought out that the level of SEMA6A-protein expression has a prognostic significance in BRAF-mut melanoma patients by regulating the remodeling of actin cytoskeleton via inducing a SEMA6A-RhoA-YAP-pathway (Loria et al. 2022). The gene discussed is BRAF; the disease is melanoma.